|Bid||19.40 x 1200|
|Ask||19.50 x 900|
|Day's Range||19.23 - 19.70|
|52 Week Range||13.00 - 25.59|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||38.86|
|Earnings Date||Nov 05, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||28.29|
As you might know, Collegium Pharmaceutical, Inc. (NASDAQ:COLL) just kicked off its latest third-quarter results with...
Image source: The Motley Fool. Collegium Pharmaceutical Inc (NASDAQ: COLL)Q3 2020 Earnings CallNov 6, 2020, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGreetings, and welcome to the Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of 39.13% and 1.61%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?